Skip to main content
Sat, Mar 21, 2026
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
ScienceUnited States1 sourcesNeutral

In the clinic for March 20, 2026

Clinical updates for biopharma and med tech, including data readouts and publications: AC Immune, AL-S Pharma, C2N, Causeway, Clearmind, Kelun-Biotech, Pfizer, Totus, Vaxcyte.

Bioworld
via Bioworld

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments
Be respectful and constructive.
Loading comments...